List of insiders holdings for HYPERION DEFI INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Grant Stuart M. 10% Owner | 2024-12-04 16:12:20 | 3,942,361 0 | 3,942,361 | Form 13D |
| 2 | Yoshida Shuhei Director 10% Owner | 2021-08-24 06:03:38 | 1,751,900 0 | 1,751,900 | Form 13D |
| 3 | Senju Pharmaceutical Co. Ltd. 10% Owner | 2018-02-09 10:25:39 | 1,718,566 0 | 1,718,566 | Form 4 |
| 4 | ESHELMAN FREDRIC N Director | 2023-02-13 16:06:08 | 1,708,548 0 | 1,708,548 | Form 13D |
| 5 | Jung Hyunsu See Remarks | 2025-12-30 16:00:22 | 1,417,676 0 | 1,417,676 | Form 4 |
| 6 | MARIO ERNEST Director | 2021-11-22 09:11:37 | 392,359 0 | 392,359 | Form 4 |
| 7 | Knox David R. Chief Financial Officer | 2026-04-01 17:00:14 | 307,119 0 | 307,119 | Form 4 |
| 8 | Avenue Capital Management II L.P. Avenue Venture Opportunities Fund L.P. Avenue Venture Opportunities Fund II L.P. LASRY MARC 10% Owner | 2025-09-19 09:45:03 | 240,124 0 | 240,124 | Form 13D |
| 9 | Jones Andrew D. Chief Financial Officer | 2024-09-03 08:07:56 | 200,000 0 | 200,000 | Form 4 |
| 10 | Clauson Luke VP Research & Development | 2021-06-17 09:20:57 | 128,258 0 | 128,258 | Form 4 |
| 11 | Strahlman Ellen R Director | 2025-12-30 16:01:21 | 91,161 34,869 | 126,030 | Form 4 |
| 12 | Walters Happy David Director | 2025-12-19 19:21:59 | 111,930 0 | 111,930 | Form 4 |
| 13 | LEE KENNETH B JR Director | 2022-06-21 14:19:28 | 95,313 0 | 95,313 | Form 4 |
| 14 | GELTZEILER MICHAEL S Director | 2025-12-19 11:00:04 | 88,015 0 | 88,015 | Form 4 |
| 15 | Rubenstein Robert General Counsel | 2026-01-12 16:02:31 | 75,000 0 | 75,000 | Form 4 |
| 16 | Clasby Jennifer G VP, Regulatory and Clinical | 2021-07-21 12:21:49 | 66,537 0 | 66,537 | Form 4/A |
| 17 | Haller Julia A Director | 2022-06-21 14:28:42 | 61,177 0 | 61,177 | Form 4 |
| 18 | GANDOLFO JOHN P Chief Financial Officer | 2024-02-14 16:14:31 | 60,000 0 | 60,000 | Form 4 |
| 19 | JACOBSON RACHEL Director | 2025-08-20 16:48:05 | 56,301 0 | 56,301 | Form 4 |
| 20 | LaBelle Curt H Director | 2021-11-22 09:07:26 | 51,889 0 | 51,889 | Form 4 |
| 21 | Kern Bren Chief Operating Officer | 2025-04-23 21:33:11 | 50,031 0 | 50,031 | Form 4 |
| 22 | SUN ANTHONY Y Director | 2021-11-22 09:16:47 | 35,975 0 | 35,975 | Form 4 |
| 23 | Ianchulev Tsontcho Director | 2025-04-29 19:52:41 | 10,122 7,658 | 17,780 | Form 4/A |
| 24 | MATHER CHARLES E IV Director | 2025-04-29 19:56:40 | 9,950 0 | 9,950 | Form 4/A |
| 25 | Rowe Michael M Chief Executive Officer | 2025-07-09 16:03:45 | 7,975 0 | 7,975 | Form 4 |
| 26 | Benjamin Stephen Keith Director | 2022-06-29 09:10:24 | 4,745 0 | 4,745 | Form 4/A |
| 27 | Palanki Ram Director | 2025-04-29 19:57:08 | 4,235 0 | 4,235 | Form 4/A |